Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Pantaleo: Poxvirus-Based Vaccine Development |
| Strategy: | Combo: DNA & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2011-12-14 |
| Study Made Public: | 2013-08-13 |
Title
DNA Immunization Schedule Study
Description
CAVD 277 (AUP485/CAVIMC-040) is a non-human primate study comparing 3 different prime/boost regimens using DNA-C, NYVAC-C, and protein vaccines.
Sign in to see full information about this study and to download study data.
Products
NYVAC-C (vP2010) MF59 DNA-C gp120 C.1086 gp120 TV1Integrated data
BAMA, ICS, ELISpot, NAb
Non-integrated data
No non-integrated data is available for this study.